Journal
JOURNAL OF CLINICAL MEDICINE
Volume 9, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/jcm9082467
Keywords
VTE; PE; DVT; prophylaxis; prevention; epidemiology; COVID; cancer
Categories
Funding
- Hamilton Health Sciences
- McMaster University Department of Medicine
Ask authors/readers for more resources
Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
